Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, Andreas, Grund, Stefanie, Mui, Barbara L, Hope, Michael J, Baumhof, Patrick, Fotin-Mleczek, Mariola, Schlake, Thomas·2015·Molecular Therapy

DOI 10.1038/mt.2015.103

Cited by (514)

Items 301–400 of 514

mRNA Vaccines: Current Applications and Future Directions
Jianmei Li, Yixin Liu, Jie Dai, Yang Li, Feng Xiong, Jing Xia, Jing Jin, Yangping Wu, Xingchen Peng · 2025 · MedComm
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset
Ying Xiong, Aowen Wang, Yu Kang, Chao Shen, Chang‐Yu Hsieh, Tingjun Hou · 2025 · Nature Communications
Not so cold! Improving the thermostability of mRNA vaccines
Jean Haensler, Luc Even, Pierre Wils, Fethi Bensaid, Anusha Dias, Hongfeng Deng, Shrirang Karve, Frank DeRosa · 2025 · Expert Review of Vaccines
Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens
Mohamad‐Gabriel Alameh, Drew Weissman · 2022 · Elsevier eBooks
An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches
Md. Habib Ullah Masum, Shah Wajed, Md. Imam Hossain, Nusrat Rahman Moumi, Asma Talukder, Md. Mijanur Rahman · 2024 · PLoS ONE
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
Srdan Tadic, Alfredo Martı́nez · 2024 · Frontiers in Immunology
Co-delivery of NS1 and BMP2 mRNAs to murine pluripotent stem cells leads to enhanced BMP-2 expression and osteogenic differentiation
Pinpin Wang, Delphine Logeart‐Avramoglou, Hervé Petite, Cristine Gonçalves, Patrick Midoux, Federico Perche, Chantal Pichon · 2020 · Acta Biomaterialia
Exciting Times for Lipid Nanoparticles: How Canadian Discoveries Are Enabling Gene Therapies
Miffy H. Y. Cheng, Cedric A. Brimacombe, Rein Verbeke, Pieter R. Cullis · 2022 · Molecular Pharmaceutics
mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient Fibroblasts
Denzil L. Furtado, Christina Cortez‐Jugo, Ya Hui Hung, Ashley Ian Bush, Frank Caruso · 2022 · Molecular Pharmaceutics
Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome
Norman Michael Drzeniek, Nourhan Kahwaji, Stephan Schlickeiser, Petra Reinke, Sven Geißler, Hans‐Dieter Volk, Manfred Gossen · 2022 · Biomaterials
Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens
Zhaoyang Wang, Chongyu Tian, Junyu Zhu, Shiqian Wang, Xiang Ao, Yanjuan He, Huixin Chen, Xiuying Liao, Deming Kong, Yong-Fei Zhou et al. · 2025 · Journal of Nanobiotechnology
Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies
Munazza Fatima, Timothy An, Kee‐Jong Hong · 2025 · Biomolecules
Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
Darin K. Edwards, Andrea Carfı́ · 2022 · Current Opinion in Immunology
Translation of in vitro-transcribed RNA therapeutics
Tobias von der Haar, Thomas E. Mulroney, Fábio de Lima Hedayioglu, Sathishkumar Kurusamy, Maria A. Rust, Kathryn Susan Lilley, James E. D. Thaventhiran, Anne E. Willis, Christopher Mark Smales · 2023 · Frontiers in Molecular Biosciences
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth
Hsuan-Yuan Wang, Leike Li, Cody S. Nelson, Richard Barfield, Sarah M. Valencia, Cliburn C. W. Chan, Hiromi Muramatsu, Paulo J.C. Lin, Norbert Pardi, Zhiqiang An et al. · 2024 · npj Vaccines
The mRNA vaccine platform for veterinary species
Fatemeh Fazel, Janan Shoja Doost, Sugandha Raj, Nitish Boodhoo, Khalil Karimi, Shayan Sharif · 2024 · Veterinary Immunology and Immunopathology
RNA Engineering for Public Health: Innovations in RNA-Based Diagnostics and Therapeutics
Walter Thavarajah, Laura M. Hertz, David Z. Bushhouse, Chloé M. Archuleta, Julius B. Lucks · 2021 · Annual Review of Chemical and Biomolecular Engineering
The patent maze of COVID 19 vaccines
Ulrich Storz · 2021 · Expert Opinion on Therapeutic Patents
Co-delivery of mRNA and SPIONs through amino-ester nanomaterials
Xiao Ling Luo, Weiyu Zhao, Bin Li, Xinfu Zhang, Chengxiang Zhang, Anna Bratasz, Binbin Deng, David W. McComb, Yizhou Dong · 2018 · Nano Research
Advancing vaccine technology through the manipulation of pathogenic and commensal bacteria
Khristine Kaith S. Lloren, Amal Senevirathne, John Hwa Lee · 2024 · Materials Today Bio
Navigating the next frontier in biomedicine: breakthroughs and insights in nucleic acid therapeutics
Shanchao Wu, Zhihui Zhang, Zilong Zhao, Cheng Cui, Weihong Tan · 2026 · Chemical Science
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Wubetu Yihunie Belay, Getinet Nibret, Yibeltal Aschale · 2023 · Clinical Pharmacology Advances and Applications
mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
Sarfaraz K. Niazi, Matthias Magoola · 2023 · Biologics
Advances in Development of mRNA-Based Therapeutics
Lei Huang, Luyao Zhang, Weiwei Li, Shiqiang Li, Jianguo Wen, Hangwen Li, Zhongmin Liu · 2020 · Current topics in microbiology and immunology
mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model
Maximiliano L. Cacicedo, Christine Weinl-Tenbruck, Daniel Frank, Sebastian Wirsching, Beate Katharina Straub, Jana Hauke, Jürgen G. Okun, Nigel Horscroft, Julia B. Hennermann, Fred Zepp et al. · 2022 · Molecular Therapy — Methods & Clinical Development
Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine
Haiqin Ping, Wenjun Yu, Xiaoming Gong, Xin Tong, Cheyu Lin, Zhaojun Chen, Caiyun Cai, Kai Guo, Hengning Ke · 2022 · Investigational New Drugs
Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden
Mary G. Krauland, Richard Kent Zimmerman, Katherine V. Williams, Jonathan M. Raviotta, Lee H. Harrison, John V. Williams, Mark S. Roberts · 2022 · Vaccine X
The optimization strategies of LNP-mRNA formulations: Development and challenges for further application
Sizhen Wang, Beibei Guo, Huan Wang, Feng Yang · 2024 · Journal of Drug Delivery Science and Technology
RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems
Uchechukwu Odunze, Nitin Rustogi, Paul Devine, Lorraine Miller, Sara G. T. Pereira, Surender Vashist, Harm Jan Snijder, Dominic J. Corkill, Alan Sabirsh, Julie A. Douthwaite et al. · 2024 · Nucleic Acids Research
1mΨ influences the performance of various positive-stranded RNA virus-based replicons
Paola Miyazato, Takafumi Noguchi, Fumiyo Ogawa, Takeshi Sugimoto, Yuzy Fauzyah, Ryo Sasaki, Hirotaka Ebina · 2024 · Scientific Reports
A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25
Cyrielle E. Fougeroux, Sven Hendrik Hagen, Louise Goksøyr, Kara-Lee Aves, Anna Kathrine Okholm, Candice Morin, Abhijeet Girish Lokras, Saahil Sandeep Baghel, Camilla Foged, Marga van de Vegte‐Bolmer et al. · 2025 · Nature Nanotechnology
Messenger RNA as a Novel Therapeutic Approach
Matthew G. Stanton, Kerry E. Murphy-Benenato · 2017 · Topics in medicinal chemistry
Development of a novel circular mRNA vaccine of six protein combinations against Staphylococcus aureus
Fei Zhu, Shiyang Ma, Haicheng Wen, Mingjun Rao, Peipei Zhang, Wenzhong Peng, Yanhui Cui, Hang Yang, Caixia Tan, Jie Chen et al. · 2022 · Journal of Biomolecular Structure and Dynamics
The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
Parichehr Hassanzadeh · 2021 · Life Sciences
Messenger RNA Therapy for Female Reproductive Health
Rachel VanKeulen‐Miller, Owen S. Fenton · 2024 · Molecular Pharmaceutics
Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation
Md. Mijanur Rahman, Md. Habib Ullah Masum, Rehana Parvin, Shuvo Chandra Das, Asma Talukder · 2025 · PLoS ONE · Retracted
Muscle Regeneration and RNA: New Perspectives for Ancient Molecules
Giulia Buonaiuto, Fabio Desideri, Valeria Taliani, Monica Ballarino · 2021 · Cells
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed M. Hjazi, Aiman Mohammed Baqir Al‐Dhalimy, Sajad Ali Zearah, Pallavi Ghildiyal, Zuhair I. Al‐Mashhadani, Yasser Fakri Mustafa, Manar Mohammed Hizam, Ahmed Elawady · 2024 · Cell Biochemistry and Function
Advances and Strategies in Enhancing mRNA Cancer Vaccines
Miao Zhang, Shengqi Chen, Hai-Jun Hu, Yenhui Ong, Qianqian Ni · 2025 · Advanced Materials
Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA/LNP Therapies by the IQ Consortium
Joanna Grudzinska‐Goebel, Manuela Braun, Linzhi Chen, Swati Gupta, Sabine Lohmann, Pedro Morais, Tao Niu, Edit Tarcsa, Sophie Tourdot, Amir S. Youssef et al. · 2025 · Nucleic Acid Therapeutics
Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development
Fan Wang · 2023 · Clinical & Translational Oncology
SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
Qinhai Ma, Man Li, Lin Ma, Caroline Zhang, Hong Zhang, Huiling Zhong, Jian Wen, Yongsheng Wang, Zewei Yan, Wei Xiong et al. · 2023 · Frontiers in Immunology
Bioinformatics analysis to design a multi-epitope mRNA vaccine against S. agalactiae exploiting pathogenic proteins
Mahdi Barazesh, Maryam Abbasi, Mohsen Mohammadi, Mohammad naser Nasiri, Faranak Rezaei, Shiva Mohammadi, Soudabeh Kavousipour · 2024 · Scientific Reports
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
Ziqi Cheng, Junfeng Ma, Chenyan Zhao · 2024 · Vaccines
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Jin Ling, Hongwei Chen, Mengwen Huang, Jun Wang, Xiao‐Jiao Du · 2025 · Journal of Controlled Release
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
Zhimeng Wei, Shuai Zhang, Xingya Wang, Ying Xue, Sheng Dang, Jingbo Zhai · 2025 · Frontiers in Immunology
Lipidic Formulations Inspired by COVID Vaccines as Smart Coatings to Enhance Nanoparticle-Based Cancer Therapy
Marzia Conte, Marco Carofiglio, Giada Rosso, Valentina Cauda · 2023 · Nanomaterials
Metabolically stabilized double-stranded mRNA polyplexes
Jacob A. Poliskey, Samuel Thomas Crowley, Raghu Ramanathan · 2018 · Gene Therapy
Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases
Karol Marcela Córdoba, Daniel Jericó, Ana Sampedro, Lei Jiang, María J. Iraburu, Paolo G.V. Martini, Pedro Berraondo, Matias Antonio Avila, Antonio Fontanellas · 2022 · International review of cytology
Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
Ruei‐Min Lu, Kang-Hao Liang, Hsiao-Ling Chiang, Fu‐Fei Hsu, Hsiu-Ting Lin, Wan-Yu Chen, Feng-Yi Ke, Monika Kumari, Yu‐Chi Chou, Mi‐Hua Tao et al. · 2023 · Heliyon
Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression
Qianshan Qin, Huayuan Yan, Weixiang Gao, Ruyin Cao, Guopeng Liu, Xiaojing Zhang, Niangang Wang, Wenjie Zuo, Lei Yuan, Peng Gao et al. · 2024 · Journal of Molecular Biology
Research progress of mosquito-borne virus mRNA vaccines
Ning Sun, Zhiwei Su, Xiaoyan Zheng · 2024 · Molecular Therapy — Methods & Clinical Development
Studies on the Synergistic Effect of Tandem Semi-Stable Complementary Domains on Sequence-Defined DNA Block Copolymers
Xin Li, Xiaobin Dai, Yufan Pan, Yawei Sun, Bo Yang, Kun Chen, You Wang, Jiang‐Fei Xu, Yuanchen Dong, Yuhe Renee Yang et al. · 2022 · Journal of the American Chemical Society
Success of nano-vaccines against COVID-19: a transformation in nanomedicine
Manoj Kumar Sarangi, Sasmita Kumari Padhi, Gautam Rath, Sitansu Sekhar Nanda, Dong Kee Yi · 2022 · Expert Review of Vaccines
Modulation of mRNA Translation and Cell Viability by Influenza A Virus Derived Nonstructural Protein 1
Yi Liu, Zhen Hua Chia, Johannes Nathaniel Min Hui Liew, Shi Min Or, Kyle K.L. Phua · 2018 · Nucleic Acid Therapeutics
Protein-Based Systems for Translational Regulation of Synthetic mRNAs in Mammalian Cells
Hideyuki Nakanishi · 2021 · Life
Working with Miraculous Mice: Mus musculus as a Model Organism
Anick Standley, Jinhan Xie, Angelica W.Y. Lau, Lauren Grote, Andrew J. Gifford · 2024 · Current Protocols
From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies
Lifeng Xu, Chao Li, Rui Liao, Qin Xiao, Xiaoran Wang, Zhuo Zhao, Weijun Zhang, Xiaoyan Ding, Yuxue Cao, Larry Cai et al. · 2024 · Molecular Pharmaceutics
mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
Saeideh Khorshid Sokhangouy, Matine Behzadi, Shokuh Rezaei, Mahsa Farjami, Milad Haghshenas, Yahya Sefidbakht, Sina Mozaffari‐Jovin · 2025 · Biotechnology Journal
Immunogenicity and innate immunity to high-dose and repeated vaccination of modified mRNA versus unmodified mRNA
Olivia Engstrand, Gustav Joas, Marcos C. Miranda, Xianglei Yan, Klara Lenart, Rodrigo Arcoverde Cerveira, Annika Reinhardt, Karin Loré · 2025 · Molecular Therapy — Nucleic Acids
Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus
Shuo Wang, Ziling Zhu, Jianmin Li · 2024 · Molecular Pharmaceutics
Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses
Elijah Kolawole Oladipo, Olanrewaju D. Oyelakin, Abdulsamad Omotayo Aiyelabegan, Elizabeth O. Olajide, Victoria O. Olatayo, Kaothar P. Owolabi, Yewande B. Shittu, Rhoda O. Olugbodi, Hezekiah A. Ajala, Raji A. Rukayat et al. · 2024 · Immunity Inflammation and Disease
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
Ishita N. Waghela, Katherine L. Mallory, Justin A. Taylor, Cosette G. Schneider, Tatyana Savransky, Chris J. Janse, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Evelina Angov · 2022 · Frontiers in Immunology
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies
Moritz Thran, Marion Poenisch, Hillary Danz, Nigel Horscroft, Konstantin Ichtchenko, Saul R. Tzipori, Charles B. Shoemaker · 2023 · Scientific Reports
Measuring the Adjuvant Activity of RNA Vaccines
Norbert Pardi, Drew Weissman · 2016 · Methods in molecular biology
mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, Shayan Sharif · 2024 · Viruses
Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response
Gabriel L. Costa, Giuseppe Andrea Sautto · 2025 · Expert Review of Vaccines
Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2
Jiin H. Felgner, Jenny E. Hernandez‐Davies, Erwin Strahsburger, Emily K. Silzel, Rie Nakajima, Aarti Jain, Jacob Laster, Jui-Lin Chiang, Ya-Li Tsai, Philip Louis Felgner et al. · 2025 · npj Vaccines
Biomimetic Nanoregulators Mediated Tyrosine Hydroxylase mRNA and Stimulator of Interferon Genes Antagonist Codelivery for Synergistic Therapy on Parkinson’s Disease
Lizhi Yang, Shuo Li, Chao Hou, Yukang Zhang, Linggang Cheng, Zihua Wang, Wen He, Wei Zhang · 2025 · ACS Nano
Preparing for Pandemics: RNA Vaccines at the Forefront
Jesse H. Erasmus, DEBORAH HEYDENBURG FULLER · 2020 · Molecular Therapy
Emerging trends of research on mRNA vaccines: A co-citation analysis
Juan Chen, Ting Zhang, Yan Zhen Lu, Xiaoyi Yang, Zhaolian Ouyang · 2022 · Human Vaccines & Immunotherapeutics
mRNA—From COVID-19 Treatment to Cancer Immunotherapy
W. Kŕause · 2023 · Biomedicines
Azido‐Functionalized 5′ Cap Analogues for the Preparation of Translationally Active mRNAs Suitable for Fluorescent Labeling in Living Cells
Adam Mamot, Pawel J. Sikorski, Marcin Warmiński, Joanna Kowalska, Jacek Jemielity · 2017 · Angewandte Chemie
How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics
Mouldy Sioud · 2023 · Scandinavian Journal of Immunology
Unleashing the potential of mRNA : Overcoming delivery challenges with nanoparticles
Qiang Chen, Ku-Geng Huo, Sheng‐Min Ji, Shude Pang, Tianying Sun, Yi Niu, Zi‐Hao Jiang, Peng Zhang, Shu‐Xin Han, Jinyao Li · 2024 · Bioengineering & Translational Medicine
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
D. N. Kisakov, Л. И. Карпенко, L. A. Kisakova, Sergey V. Sharabrin, Mariya Borisovna Borgoyakova, Ekaterina V. Starostina, Oleg Svyatoslavovich Taranov, Elena K. Ivleva, Oleg V. Pyankov, Anna V. Zaykovskaya et al. · 2025 · Vaccines
EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma
Weiwei Zhang, Chuang Wang, Yousheng Meng, Lang He, Mingqing Dong · 2025 · Vaccines
Multi-objective computational optimization of human 5′ UTR sequences
Keisuke Yamada, Kanta Suga, Naoko Abe, Koji Hashimoto, Susumu Tsutsumi, Masahito Inagaki, Fumitaka Hashiya, Hiroshi Abe, Michiaki Hamada · 2025 · Briefings in Bioinformatics
Improvement in the potency of a N1-methylpseudouridine-modified self-amplifying RNA through mutations in the RNA-dependent RNA polymerase
Verónica M. Quintana, Josefina Caillava, Laura A. Byk, Juan A. Mondotte, Leandro Battini, Prutha Tarte, Marcelo M. Samsa, Claudia V. Filomatori, Diego Ezequiel Alvarez · 2025 · Journal of Biological Chemistry
Recent Developments of RNA Vaccines and Therapeutics: Reagents, Formulations, and Characterization
Mhd Anas Tomeh, Rachel K. Smith, Allan Watkinson · 2025 · Molecular Pharmaceutics
Innovative translational platforms for rapid developing clinical vaccines against COVID‐19 and other infectious disease
Ning Wang, Ting Wang · 2024 · Biotechnology Journal
mRNA as a Therapeutics: Understanding mRNA Vaccines
Ferdi Oğuz, Harika Atmaca · 2021 · Advanced Pharmaceutical Bulletin
From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion
John F. Atkins, Kate M. O’Connor, Pramod R. Bhatt, Gary Loughran · 2021 · Viruses
Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
Lorena Leonardelli, Giuseppe Lofano, Gianluca Selvaggio, Silvia Parolo, Stefano Giampiccolo, Danilo Tomasoni, Enrico Domenici, Corrado Priami, Haifeng Song, Duccio Medini et al. · 2021 · Frontiers in Immunology
Serological response to a single dose of a SARS-CoV-2 mRNA vaccine
Angélica Ramos, Maria João Cardoso, Pedro M. P. N. S. Norton · 2021 · Journal of Virological Methods
E2-based mRNA vaccine encapsulated in lipid nanoparticles protects pigs against classical swine fever virus
Jingyi Liu, Yingju Xia, Chuanwen Tian, Ziyu Chen, Weiqiang Guo, Yingnan Liu, Jing A. Wen, Zhenhua Xie, Jinzhong Lin, Jiaxin Li et al. · 2025 · Journal of Virology
Harnessing the Potential of mRNA Vaccines Against Infectious Diseases
Nouran Rezk, Siobhán McClean · 2025 · Microbial Biotechnology
Chemical Modifications in Nucleic Acid Therapeutics
Kim A. Lennox, Rebecca C. Young, Mark A. Behlke · 2025 · Methods in molecular biology
Towards mRNA therapeutics 2.0
Kenneth R. Chien, Kylie S. Foo, Nevin Witman · 2026 · Nature Reviews Drug Discovery
A Review of Recent Advances in Peptide-Based Anticancer Therapeutic Vaccines and Nanovaccines in Prostate Cancer
Ali Khezrian, Mazaher Ahmadi, Pooneh Mokarram · 2023 · International Journal of Peptide Research and Therapeutics
Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review
Smita Pawar, Prashant Pingale, Atul Garkal, Riyaz Ali M. Osmani, Kavita Rai Gajbhiye, Madhur Kulkarni, Krutika Pardeshi, Tejal A Mehta, Amarjitsing Rajput · 2024 · International Journal of Biological Macromolecules
Recent strategies for enhanced delivery of mRNA to the lungs
Brittany J. Heiser, Arian Veyssi, Debadyuti Ghosh · 2025 · Nanomedicine
Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA
Jeffrey B. Ulmer, Margaret A. Liu · 2021 · Molecular Frontiers Journal
Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and 18F-FDG PET/CT features.
Narjess Ayati, Scott Evans, Seyed Rasoul Zakavi · 2023 · PubMed
Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history
Steve Pascolo · 2023 · European Journal of Immunology
Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment
Paa Kwesi Ankrah, Ajibola Olaoluwa Ilesanmi, Amos Olalekan Akinyemi, Victor Lasehinde, Oluwapelumi Eniola Adurosakin, Oluwatobi H Ajayi · 2023 · Cureus
mRNA-based vaccines – global approach, challenges, and could be a promising wayout for future pandemics
Shivani Makhijani, Gehan M. Elossaily, Satish V. Rojekar, Rahul G Ingle · 2024 · Pharmaceutical Development and Technology
A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Christopher J. A. Warner, Subrata Dutta, Alejandro R. Foley, Jevgenij A. Raskatov · 2017 · Journal of Visualized Experiments
Controlling Protein Expression by Delivery of RNA Therapeutics Using Lipid Nanoparticles
Paulo J.C. Lin, Ying K. Tam · 2019 · Elsevier eBooks
PCR-generated DNA templates enable efficient, rapid, and cost-effective mRNA synthesis
Naveen Kumar, Nicholas C. Hazell, Jiani Bei, Tina K. Nguyen, Haitao Hu · 2025 · Methods